Sponsored Links

FDA Announces New Safety Recommendations For High-Dose Simvastatin PDF Print E-mail
Medical News - Cholesterol
The U.S. Food and Drug Administration today is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose--80 milligram (mg)--has been associated with an elevated risk of muscle injury or myopathy, particularly during the first 12 months of use...

Read more: Cholesterol News From Medical News Today